drugset / Trial / NCT00409708

Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)

NCT00409708

Phase 2 Completed 142 enrolled Novartis
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will assess the frequency of chromosomal abnormalities measured in circulating lymphocytes in treatment-naive children with Attention Deficit Hyperactivity Disorder (ADHD) treated for 3 months with either extended release methylphenidate or behavioral therapy.

Timeline

Start
2006-11
Primary completion
2008-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylphenidate Small molecule